Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × Sorafenib × Clear all

NCT01159327 2015-11-11

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Phase 2 Terminated

Small Cell Lung Carcinoma